Similarly, in 2017, Li’s team found that the mRNA and protein levels of FGF18 in tissue samples of HCC patients and human liver cancer cell lines HepG2 and HuH7 were significantly higher than those in normal liver tissue and human normal liver epithelial cell line LO2 (34). This evidence concerns the gene FGF18 and hepatocellular carcinoma.